Literature DB >> 19676094

The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia.

Katherine J O'Malley, Rajiv Dhir, Joel B Nelson, James Bost, Yan Lin, Zhou Wang.   

Abstract

BACKGROUND: Benign prostatic hyperplasia (BPH) is one of the most common diseases among aging men in the United States. In addition to aging, the presence of androgens is another major risk factor in BPH development. However, whether androgen signaling is altered in BPH remains unclear. To determine androgen signaling in BPH, we characterized the expression of four different androgen-responsive genes, Eaf2/U19, ELL2, FKBP5, and PSA, in BPH and adjacent normal glandular epithelial cells.
METHODS: A set of 17 BPH specimens were resected from patients over 60 years of age with clinical symptoms of BPH. Laser-capture microdissection (LCM) was used to isolate glandular epithelial cells from BPH areas and adjacent normal areas, separately. LCM isolated cells from individual specimens were lysed and RNA isolation, reverse transcription, and real-time PCR were performed using CellsDirect One-Step qRT-PCR Kit (Invitrogen, Carlsbad, CA).
RESULTS: All of the assayed genes displayed increased expression, from approximately 2- to approximately 6-fold, in BPH as compared to the adjacent normal epithelial cells. We also generated a composite androgen response index based on the expression levels of the four genes, which provides a reliable readout for overall androgen action. Our study showed that the composite androgen response index in BPH is approximately 4-fold as compared to that in the adjacent normal tissues.
CONCLUSIONS: Androgen signaling is significantly elevated in BPH relative to the adjacent normal prostate. Understanding the mechanisms causing elevated androgen signaling may lead to novel approaches for prevention and/or treatment of BPH. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19676094      PMCID: PMC2804845          DOI: 10.1002/pros.21034

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  49 in total

Review 1.  Hormonal signaling in prostatic hyperplasia and neoplasia.

Authors:  M Marcelli; G R Cunningham
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.

Authors:  Wuhan Xiao; Feng Jiang; Zhou Wang
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

3.  Genes regulated by androgen in the rat ventral prostate.

Authors:  Z Wang; R Tufts; R Haleem; X Cai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  ELL2, a new member of an ELL family of RNA polymerase II elongation factors.

Authors:  A Shilatifard; D R Duan; D Haque; C Florence; W H Schubach; J W Conaway; R C Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL.

Authors:  Stephanie E Kong; Charles A S Banks; Ali Shilatifard; Joan Weliky Conaway; Ronald C Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

6.  Keratinocyte growth factor in the rat ventral prostate: androgen-independent expression.

Authors:  J A Nemeth; D J Zelner; S Lang; C Lee
Journal:  J Endocrinol       Date:  1998-01       Impact factor: 4.286

Review 7.  The economics of benign prostatic hyperplasia treatment: a literature review.

Authors:  M A Kortt; J L Bootman
Journal:  Clin Ther       Date:  1996 Nov-Dec       Impact factor: 3.393

Review 8.  Androgen receptor cross-talk with cell signalling pathways.

Authors:  Zoran Culig
Journal:  Growth Factors       Date:  2004-09       Impact factor: 2.511

Review 9.  Etiology of benign prostatic hyperplasia.

Authors:  C Lee; J M Kozlowski; J T Grayhack
Journal:  Urol Clin North Am       Date:  1995-05       Impact factor: 2.241

10.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Authors:  Z Culig; A Hobisch; M V Cronauer; C Radmayr; J Trapman; A Hittmair; G Bartsch; H Klocker
Journal:  Cancer Res       Date:  1994-10-15       Impact factor: 12.701

View more
  34 in total

1.  Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes.

Authors:  Liquan Cai; Binh L Phong; Alfred L Fisher; Zhou Wang
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Targeting monoamine oxidase A in advanced prostate cancer.

Authors:  Vincent Flamand; Hongjuan Zhao; Donna M Peehl
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-04       Impact factor: 4.553

Review 3.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

4.  Effects of Estrogen Receptor β Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.

Authors:  Shinsuke Mizoguchi; Kenichi Mori; Zhou Wang; Teresa Liu; Yasuhito Funahashi; Fuminori Sato; Donald B DeFranco; Naoki Yoshimura; Hiromitsu Mimata
Journal:  Prostate       Date:  2017-02-09       Impact factor: 4.104

5.  Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.

Authors:  Yasuhito Funahashi; Katherine J O'Malley; Naoki Kawamorita; Pradeep Tyagi; Donald B DeFranco; Ryosuke Takahashi; Momokazu Gotoh; Zhou Wang; Naoki Yoshimura
Journal:  Prostate       Date:  2013-12-17       Impact factor: 4.104

6.  Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis.

Authors:  Yoshio Sugino; Katherine J O'Malley; Zhou Wang; Pradeep Tyagi; Lori A Birder; Osamu Ogawa; Naoki Yoshimura
Journal:  Int Urol Nephrol       Date:  2015-02-14       Impact factor: 2.370

7.  Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.

Authors:  Shinsuke Mizoguchi; Kenichi Mori; Toshitaka Shin; Zhou Wang; Donald B DeFranco; Naoki Yoshimura; Hiromitsu Mimata
Journal:  Prostate       Date:  2020-09-17       Impact factor: 4.104

8.  A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments.

Authors:  Lauren Brady; Rui M Gil da Costa; Ilsa M Coleman; Clinton K Matson; Michael C Risk; Roger T Coleman; Peter S Nelson
Journal:  Prostate       Date:  2020-02-18       Impact factor: 4.104

9.  N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization.

Authors:  Javid A Dar; Kurtis Eisermann; Khalid Z Masoodi; Junkui Ai; Dan Wang; Tyler Severance; Sharanya D Sampath-Kumar; Zhou Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-04       Impact factor: 4.292

10.  Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Authors:  Ferenc G Rick; Andrew Abi-Chaker; Luca Szalontay; Roberto Perez; Miklos Jaszberenyi; Arumugam R Jayakumar; Nagarajarao Shamaladevi; Karoly Szepeshazi; Irving Vidaurre; Gabor Halmos; Awtar Krishan; Norman L Block; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.